About: Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebmed/2007/volume_12/issue_2/w
Subject	Diabetes Drugs: cardiovascular system Epidemiologic studies Radiology (diagnostics) Clinical diagnostic tests Stroke thiazolidinediones Therapuetics Ischaemic heart disease diabetes mellitus (type 2) hypoglycemic agents Clinical trials (epidemiology) Radiology
Title	Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebmed/2007/volume_12/issue_2/B3555EDB3F2D38C5E053120B220A16A6/m/print http://hub.abes.fr/bmj/periodical/ebmed/2007/volume_12/issue_2/B3555EDB3F2D38C5E053120B220A16A6/m/web
related by	http://hub.abes.fr/bmj/periodical/ebmed/2007/volume_12/issue_2/B3555EDB3F2D38C5E053120B220A16A6/authorship/1
article type	research-article
is part of this journal	Evidence Based Medicine
PubMed ID	17400645

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata